Brainstorm Cell Therapeutics Inc.
Report top-line data from the Progressive MS Phase 2 clinical trial
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Feb 2021
- Due
- 31 Mar 2021
- Delivered
- 24 Mar 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Progressive MS Phase 2 trial remains on track for top-line data readout in Q1 2021”
What we found
Evidence strength A What the grades mean
The company announced the top-line data from its Phase 2 Progressive MS clinical trial on March 24, 2021, which falls within the first quarter of 2021.
-
A Brainstorm Cell Therapeutics Inc. 10-K filed 2022-03-28
“On March 24, 2021, the Company announced positive top-line data in the Phase 2 study evaluating three repeated administrations of NurOwn®” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Progressive MS Phase 2 trial top-line data
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Brainstorm Cell Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-BCLI-023099 · Corrections policy